Avidity Biosciences (RNAM) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

• Last SEC data release: 2026-02-13
• Last 15 days FTD volume: A$0.73 M
• Last 3 months FTD volume: A$15.02 M
• Last 12 months FTD volume: A$47.22 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNAM) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNAM) - since 2020

Avidity Biosciences (RNAM) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	A$45.02 M	A$0.12 B	🇺🇸 USA
GSK plc GSK	A$28.21 M	A$0.27 B	🇬🇧 UK
Sarepta Therapeutics SRPT	A$4.82 M	A$23.17 M	🇺🇸 USA
PTC Therapeutics PTCT	A$13.79 M	A$18.9 M	🇺🇸 USA
Fate Therapeutics FATE	A$0.03 M	A$1.29 M	🇺🇸 USA
Acorda Therapeutics ACOR	N/A	A$0.01 M	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	A$0.43 M	A$0.94 M	🇺🇸 USA